PRINCETON - PDS Biotechnology Corporation (NASDAQ:PDSB) has confirmed plans to commence its VERSATILE-003 Phase 3 clinical trial for a promising cancer immunotherapy within the first quarter of 2025.

Heartland Dental, Aspen Dental and PDS Health are the three largest DSOs and MSOs in the dental industry. Here is how the three organizations stack up based on the number of practices in their network ...